Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 20;16(1):e0245752.
doi: 10.1371/journal.pone.0245752. eCollection 2021.

The prevalence and clinical outcome of supraventricular tachycardia in different etiologies of pulmonary hypertension

Affiliations

The prevalence and clinical outcome of supraventricular tachycardia in different etiologies of pulmonary hypertension

Zdenka Fingrova et al. PLoS One. .

Abstract

Purpose: Patients with pulmonary hypertension (PH) frequently suffer from supraventricular tachycardias (SVT). The main purpose of our study was to identify the cumulative incidence of SVT in patients with different etiologies of PH. The secondary objective was to analyse the clinical impact of SVT.

Methods: We retrospectively studied the prevalence of SVT and the clinical outcome in 755 patients (41% males; 60 ± 15 years; mean follow-up 3.8 ± 2.8 years) with PH of different etiologies. The prevalence of SVT was analysed separately in isolated pre-capillary PH (Ipc-PH) and in patients with combined post- and pre-capillary PH (Cpc-PH).

Results: The prevalence of SVT in the Ipc-PH group (n = 641) was 25% (n = 162). The most prevalent arrhythmias were atrial fibrillation followed by a typical atrial flutter (17% and 4.4% of all Icp-PH patients). An excessive prevalence of SVT was found in patients with pulmonary arterial hypertension associated with congenital heart disease (35%, p = 0.01). Out of the overall study population, Cpc-PH was present in 114 (15%) patients. Patients with Cpc-PH manifested a higher prevalence of SVT than subjects with Ipc-PH (58; 51% vs. 162; 25%; p <0.0001) and were more likely to have persistent or permanent atrial fibrillation (38; 29% vs. 61; 10%; p <0.0001). Parameters significantly associated with mortality in a multivariate analysis included age, male gender, functional exercise capacity and right atrial diameter (p < 0.05). Neither diagnosis of SVT nor type of arrhythmia predicted mortality.

Conclusions: The study detected a significant prevalence of SVT in the population of PH of different origins. Different spectrum and prevalence of arrhythmia might be expected in different etiologies of PH. Patients with an elevated post-capillary pressure showed a higher arrhythmia prevalence, predominantly due to an excessive number of atrial fibrillations. The diagnosis of SVT was not associated with mortality.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. The prevalence of different supraventricular tachycardias in subgroups.
Legend: Values are expressed as n (%). Ipc-PH–isolated pre-capillary pulmonary hypertension; Cpc-PH–combined post- and pre-capillary pulmonary hypertension; PH–pulmonary hypertension; AF–atrial fibrillation; AFL–atrial flutter; SVT–supraventricular tachycardia.
Fig 2
Fig 2. Differences between patients with and without supraventricular tachycardia in relation to presence of post-capillary component.
Legend: Values are expressed as mean ± standard deviation or as n (%). Ipc-PH–isolated pre-capillary pulmonary hypertension; Cpc-PH–combined post- and pre-capillary pulmonary hypertension; PAMP–pulmonary arterial mean pressure; PAWP–pulmonary arterial wedge pressure; 6MWT–six-minute walking test; LA–left atrium; RA–right atrium.

Similar articles

Cited by

References

    1. Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67–119. 10.1093/eurheartj/ehv317 - DOI - PubMed
    1. Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2004;43(12 Suppl S):5S–12S. 10.1016/j.jacc.2004.02.037 - DOI - PubMed
    1. Wen L, Sun ML, An P, Jiang X, Sun K, Zheng L, et al. Frequency of Supraventricular Arrhythmias in Patients With Idiopathic Pulmonary Arterial Hypertension. Am J Cardiol. 2014;114(9):1420–5. 10.1016/j.amjcard.2014.07.079 - DOI - PubMed
    1. Smith B, Genuardi MV, Koczo A, Zou RH, Thoma FW, Handen A, et al. Atrial arrhythmias are associated with increased mortality in pulmonary arterial hypertension. Pulm Circ. 2018;8(3):2045894018790316. 10.1177/2045894018790316 - DOI - PMC - PubMed
    1. Olsson KM, Nickel NP, Tongers J, Hoeper MM. Atrial flutter and fibrillation in patients with pulmonary hypertension. Int J Cardiol. 2013;167(5):2300–5. 10.1016/j.ijcard.2012.06.024 - DOI - PubMed

Publication types